Realbotix Reports Q1-2026, YE-2025 Results, Nasdaq Listing via Onconetix
Analysis based on 10 articles · First reported Mar 06, 2026 · Last updated Mar 10, 2026
Realbotix's financial results, strategic shift to AI and robotics, and planned Nasdaq listing through Onconetix are expected to positively impact its stock price and investor confidence. The company's debt-free status and sufficient capital for over 12 months of operations also provide market stability.
Realbotix Corp. reported its Q1-2026 interim financial results and audited YE-2025 results. For Q1-2026, revenue was $353,037, down from $815,655 in Q1-2025, but net loss improved to $1.3 million from $1.7 million. For YE-2025, revenue increased by 121% to $2.0 million, and net loss improved to $6.3 million from $12.5 million. The company has fully repaid its debts, is debt-free, and holds approximately $8.6 million in cash. Realbotix completed a CAD$7.0 million private placement in October 2025. Key strategic moves include the disposal of cryptocurrency holdings, a focus on AI software and humanoid robot manufacturing, and a planned reverse take-over with Nasdaq-listed Onconetix to broaden its investor base. Realbotix also hired Scott Meyers as CFO and Eric Olson to lead operations, launched its AI chatbot Ask Aria, partnered with Grupo Kuo, and secured clients like Ericsson and The FUTR Corporation.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard